Literature DB >> 578220

The natural history of calcium urolithiasis.

F L Coe, J Keck, E R Norton.   

Abstract

The course of untreated calcium renal stones, derived from the retrospective study of 300 patients with defined metabolic disorders and from the analysis of two prospective, published studies, is complex and heterogeneous. Generally, stones provoke considerable morbidity; hyperuricosuria is associated with an unusually severe stone disease. Stone recurrence rates usually remain stable, or rise with successive stones; in a minority of patients, the reverse is true. A single stone is likely to be followed by a recurrence. The mean time to recurrence averages 6.78 years, with peaks at 1.56 and eight years. Because the disease is likely to be morbid and chronic and does not wane with age, diagnostic evaluation and treatment should be strongly considered for any patient with recurrent stones, and for those in whom recurrence is likely to pose more than the usual risk.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 578220

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

1.  Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones.

Authors:  Amy E Krambeck; Naseem F Khan; Molly E Jackson; James E Lingeman; James A McAteer; James C Williams
Journal:  J Urol       Date:  2010-08-21       Impact factor: 7.450

Review 2.  Clinical investigations.

Authors:  F Hering
Journal:  Urol Res       Date:  1990

3.  Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica.

Authors:  Aslam Khan; Saeed R Khan; Anwar H Gilani
Journal:  Urol Res       Date:  2012-05-24

4.  Tools to improve the accuracy of kidney stone sizing with ultrasound.

Authors:  Barbrina Dunmire; Franklin C Lee; Ryan S Hsi; Bryan W Cunitz; Marla Paun; Michael R Bailey; Mathew D Sorensen; Jonathan D Harper
Journal:  J Endourol       Date:  2014-09-17       Impact factor: 2.942

5.  Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network.

Authors:  Michelle R Denburg; Mary B Leonard; Kevin Haynes; Shamir Tuchman; Gregory Tasian; Justine Shults; Lawrence Copelovitch
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

Review 6.  Insights Into Nephrolithiasis From the Nurses' Health Studies.

Authors:  Megan L Prochaska; Eric N Taylor; Gary C Curhan
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

7.  Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains.

Authors:  John H Wiessner; Michael R Garrett; Richard J Roman; Neil S Mandel
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03

8.  Calcium oxalate nephrolithiasis and expression of matrix GLA protein in the kidneys.

Authors:  Aslam Khan; Wei Wang; Saeed R Khan
Journal:  World J Urol       Date:  2013-03-09       Impact factor: 4.226

9.  Efficacy and outcome of surgical intervention in patients with nephrolithiasis and chronic renal failure.

Authors:  I Singh; N P Gupta; A K Hemal; M Aron; P N Dogra; A Seth
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

10.  Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence?

Authors:  Hakan Hasbey Koyuncu; Faruk Yencilek; Bilal Eryildirim; Kemal Sarica
Journal:  Urol Res       Date:  2010-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.